Susquehanna International Group’s Aralez Pharmaceuticals Inc. ARLZ Stock Holding History

Susquehanna International Group’s Portfolio ARLZ Stock Details ARLZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-74,800	Closed	-$26K	–	10990
2018 Q2	$26K	Buy	74,800 +23,200	+45%	+$19K	﹤0.01%	9397
2018 Q1	$77K	Buy	51,600 +13,800	+37%	+$24.1K	﹤0.01%	8813
2017 Q4	$54K	Sell	37,800 -8,200	-18%	-$13.5K	﹤0.01%	8896
2017 Q3	$105K	Buy	+46,000	New	+$61.6K	﹤0.01%	8345
2017 Q2	–	Sell	-151,000	Closed	-$323K	–	10468
2017 Q1	$323K	Buy	151,000 +24,900	+20%	+$93.6K	﹤0.01%	7226
2016 Q4	$556K	Buy	+126,100	New	+$599K	﹤0.01%	6763
2016 Q3	–	Sell	-136,700	Closed	-$451K	–	9714
2016 Q2	$451K	Buy	136,700 +47,700	+54%	+$180K	﹤0.01%	6299
2016 Q1	$316K	Buy	+89,000	New	+$459K	﹤0.01%	7179

Other funds holding ARLZ

Glenmede Trust Philadelphia, Pennsylvania $22.7B AUM

Susquehanna International Group's ARLZ Position: Q3 2018 in Review

Susquehanna International Group sold out of Aralez Pharmaceuticals Inc. (ARLZ) in Q3 2018, closing a stake of 39,211 shares — an estimated $14K sold.

Susquehanna International Group first reported a position in ARLZ in Q1 2016 and held it in 10 quarters. The position peaked at $1.12M in Q3 2016. 4 funds tracked by Wall St. Rank hold ARLZ as of Q3 2018.

Susquehanna International Group reported no remaining Aralez Pharmaceuticals Inc. position as of Q3 2018 after selling out during the quarter.
Susquehanna International Group sold 39,211 Aralez Pharmaceuticals Inc. shares in Q3 2018, an estimated $14K.
Susquehanna International Group first reported a position in Aralez Pharmaceuticals Inc. in Q1 2016 and held it in 10 quarters.
Susquehanna International Group's Aralez Pharmaceuticals Inc. position peaked at $1.12M in Q3 2016.
4 funds tracked by Wall St. Rank held Aralez Pharmaceuticals Inc. as of Q3 2018.

Based on Susquehanna International Group's 13F filing for Q3 2018, filed 14 Nov 2018.